SK19242000A3 - Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu - Google Patents

Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu Download PDF

Info

Publication number
SK19242000A3
SK19242000A3 SK1924-2000A SK19242000A SK19242000A3 SK 19242000 A3 SK19242000 A3 SK 19242000A3 SK 19242000 A SK19242000 A SK 19242000A SK 19242000 A3 SK19242000 A3 SK 19242000A3
Authority
SK
Slovakia
Prior art keywords
seq
nucleotides
amino acids
nucleic acid
amino
Prior art date
Application number
SK1924-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas Schupp
James Madison Ligon
Istvan Molnar
Ross Zirkle
J�Rn G�Rlach
Devon Cyr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK19242000A3 publication Critical patent/SK19242000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SK1924-2000A 1998-06-18 1999-06-16 Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu SK19242000A3 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US10163198P 1998-09-24 1998-09-24
US11890699P 1999-02-05 1999-02-05
PCT/EP1999/004171 WO1999066028A2 (en) 1998-06-18 1999-06-16 Genes for the biosynthesis of epothilones

Publications (1)

Publication Number Publication Date
SK19242000A3 true SK19242000A3 (sk) 2001-07-10

Family

ID=27378840

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1924-2000A SK19242000A3 (sk) 1998-06-18 1999-06-16 Izolovaná molekula nukleovej kyseliny kódujúca polypeptid zúčastňujúci sa biosyntézy epotilónov, chimérický gén, rekombinantný vektor a rekombinantná hostiteľská bunka obsahujúce túto nukleovú kyselinu, spôsob prípravy epotilónu a izolovaný polypeptid obsahujúci epotilónsyntázovú doménu

Country Status (16)

Country Link
EP (1) EP1088078A2 (no)
JP (3) JP2002518004A (no)
KR (1) KR100511233B1 (no)
CN (1) CN100374565C (no)
AU (1) AU753567B2 (no)
BR (1) BR9911349A (no)
CA (1) CA2329774A1 (no)
HU (1) HUP0102186A3 (no)
ID (1) ID29128A (no)
IL (3) IL139735A0 (no)
NO (2) NO20006195L (no)
NZ (1) NZ508326A (no)
PL (1) PL200157B1 (no)
SK (1) SK19242000A3 (no)
TR (1) TR200003759T2 (no)
WO (1) WO1999066028A2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
KR100851418B1 (ko) * 1998-11-20 2008-08-08 코산 바이오사이언시즈, 인코포레이티드 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
DE60114865T2 (de) * 2000-04-28 2006-07-27 Kosan Biosciences, Inc., Hayward Heterologe herstellung von polyketiden
AU2002213248A1 (en) 2000-10-13 2002-04-22 The University Of Mississipi Synthesis of epothilones and relates analogs
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
DK1483251T3 (da) 2002-03-12 2010-04-12 Bristol Myers Squibb Co C3-cyano-epothilon-derivater
JP4971997B2 (ja) * 2005-01-31 2012-07-11 メルク・シャープ・エンド・ドーム・コーポレイション プラスミドdnaの精製方法
AU2012211052A1 (en) 2011-01-28 2013-09-05 Amyris, Inc. Gel-encapsulated microcolony screening
BR112013027954A2 (pt) 2011-05-13 2017-01-17 Amyris Inc métodos e composições para detectar a produção microbiana de compostos imiscíveis em água
WO2014025941A1 (en) 2012-08-07 2014-02-13 Jiang Hanxiao Methods for stabilizing production of acetyl-coenzyme a derived compounds
CN105189772B (zh) 2013-03-15 2019-09-13 阿迈瑞斯公司 磷酸转酮酶和磷酸转乙酰酶生产乙酰-辅酶a衍生化合物的用途
AU2013397496B2 (en) 2013-08-07 2020-03-12 Amyris, Inc. Methods for stabilizing production of acetyl-coenzyme a derived compounds
WO2016210350A1 (en) 2015-06-25 2016-12-29 Amyris, Inc. Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4274583B2 (ja) * 1996-11-18 2009-06-10 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) エポチロンc,d,e及びf、製造と薬剤

Also Published As

Publication number Publication date
JP2008092958A (ja) 2008-04-24
KR100511233B1 (ko) 2005-08-31
BR9911349A (pt) 2001-03-13
CA2329774A1 (en) 1999-12-23
CN100374565C (zh) 2008-03-12
NO20006195L (no) 2001-02-16
PL345579A1 (en) 2001-12-17
HUP0102186A2 (hu) 2001-10-28
WO1999066028A2 (en) 1999-12-23
CN1305530A (zh) 2001-07-25
EP1088078A2 (en) 2001-04-04
AU4611699A (en) 2000-01-05
NO20091055L (no) 2001-02-16
JP2002518004A (ja) 2002-06-25
IL139735A0 (en) 2002-02-10
NZ508326A (en) 2003-10-31
IL190391A0 (en) 2008-11-03
NO20006195D0 (no) 2000-12-06
ID29128A (id) 2001-08-02
IL139735A (en) 2009-06-15
HUP0102186A3 (en) 2005-10-28
WO1999066028A3 (en) 2000-06-29
TR200003759T2 (tr) 2001-06-21
AU753567B2 (en) 2002-10-24
KR20010052962A (ko) 2001-06-25
PL200157B1 (pl) 2008-12-31
JP2006061166A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
US6355458B1 (en) Genes for the biosynthesis of epothilones
KR100511233B1 (ko) 에포틸론 생합성 유전자
AU753546B2 (en) Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents
US7172884B2 (en) Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
CN1298447A (zh) 生产刺糖噻杀虫剂所用的生物合成基因
SK12402000A3 (sk) Spôsob fermentačnej prípravy cytostatík a ich kryštalických foriem
CN101809030A (zh) 硫肽前体蛋白质、编码该蛋白质的基因及其用途
CN100374566C (zh) 用于epothilone生物合成的基因
JP2023012549A (ja) 改変ストレプトマイセス・フンジシディカス分離株およびその使用
KR20050050146A (ko) 글리코펩티드 항생제 a40926의 생합성을 위한 유전자및 단백질
MXPA00012342A (en) Genes for the biosynthesis of epothilones
CZ20004693A3 (cs) Izolovaná nukleová kyselina kódující polypeptid účastnící se biosyntézy epothilonu, chimérický gen, vektor a hostitelské buňky obsahující tuto nukleovou kyselinu
RU2265054C2 (ru) Рекомбинантная клетка-хозяин (варианты) и клон вас
CA2381427A1 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
RU2234532C2 (ru) Нуклеиновая кислота (варианты), ее использование для экспрессии эпотилонов, полипептид (варианты), клон бактерий е.coli
RU2773311C2 (ru) Модифицированные изоляты streptomyces fungicidicus и их применение
CN1041182A (zh) 抗生素ge2270
HK1113387B (en) Microorganism producing epothilone

Legal Events

Date Code Title Description
FC9A Refused patent application